Role of the gap junction in ischemic preconditioning in the heart.
about
Functional analysis and regulation of purified connexin hemichannelsGap junctionsGap junctions and blood-tissue barriersMitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis.Contribution of intracellular calcium and pH in ischemic uncoupling of cardiac gap junction channels formed of connexins 43, 40, and 45: a critical function of C-terminal domain.Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression.RETRACTED: Glycogen synthase kinase 3β transfers cytoprotective signaling through connexin 43 onto mitochondrial ATP-sensitive K+ channels.MAS C-Terminal Tail Interacting Proteins Identified by Mass Spectrometry- Based Proteomic Approach.Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotectionDual Effects of Bilirubin on the Proliferation of Rat Renal NRK52E Cells and ITS Association with Gap Junctions.A Cell-Based Assay to Assess Hemichannel FunctionPharmacological modulation of connexin-formed channels in cardiac pathophysiology.Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury.A matter of life, death and diseases: mitochondria from a proteomic perspective.Ischemic Conditioning and Atrial Fibrillation: Hope for a NewTherapy?Role of connexin-43 in protective PI3K-Akt-GSK-3β signaling in cardiomyocytes.Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury.Lack of cardiac nerve sprouting after intramyocardial transplantation of bone marrow-derived stem cells in a swine model of chronic ischemic myocardiumNitric oxide, PKC-ε, and connexin43 are crucial for ischemic preconditioning-induced chemical gap junction uncoupling.Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.Inhibition of connexin 26 by the AMP-activated protein kinase.
P2860
Q26829380-FC52D306-E159-4B2C-A5A5-80F3E4963035Q26850591-94514A50-236B-4399-A815-06FE34714ECEQ33941978-0AE52696-A15D-451F-AC27-C19F681F8717Q34620765-C996A724-394B-4749-9C68-29DD2E4A1A01Q34639967-78E8741E-0563-4507-9673-931A09CD73ACQ35088018-0603D780-8143-482E-82AE-450086340C15Q35749776-DD5FDEC5-2425-4F90-9B97-77EE38E56141Q35814372-B49D17B6-67F9-4569-8570-8FDD0FEFE453Q36141133-277C4897-5FE6-4ECB-B22A-58DF20F49BB2Q36927926-3E7153F3-14C4-467D-BC1D-C3B3B99CDC70Q37724410-1B908483-FA00-4D86-984C-B30857633516Q37832276-A880FBC0-415E-4EF0-B76F-DC23D14942EDQ37913053-AA3AA726-47D5-431C-B75C-640503050AACQ38081957-A41B7DF0-445C-4279-8CFB-FEB735243B2BQ38790542-372AAA25-5CD5-47E5-AB79-4B41CF7C4898Q39364308-BD09C043-51D6-48C4-B277-5EB08309C44FQ41131251-E20C4AAF-D11D-4541-976D-097E5203B0E8Q41883722-819272BC-65F0-4990-AE65-97B136493B1EQ41974450-262EC382-93CF-4D84-A6F7-07CA4B291538Q47770967-905B1581-6522-4B94-8DA9-FE6F9EE325C0Q48679614-8F8CC8E3-B36D-4D7A-86C5-B77BAD106F35
P2860
Role of the gap junction in ischemic preconditioning in the heart.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the gap junction in ischemic preconditioning in the heart.
@en
Role of the gap junction in ischemic preconditioning in the heart.
@nl
type
label
Role of the gap junction in ischemic preconditioning in the heart.
@en
Role of the gap junction in ischemic preconditioning in the heart.
@nl
prefLabel
Role of the gap junction in ischemic preconditioning in the heart.
@en
Role of the gap junction in ischemic preconditioning in the heart.
@nl
P2093
P2860
P1476
Role of the gap junction in ischemic preconditioning in the heart.
@en
P2093
Takayuki Miki
Tetsuji Miura
Toshiyuki Yano
P2860
P304
P356
10.1152/AJPHEART.00879.2009
P577
2010-01-29T00:00:00Z